A study of community-acquired Mycoplasma pneumoniae in Yantai, China.

ABSTRACT:

Introduction

Community-acquired pneumonia (CAP) is a global disease responsible for a large number of deaths, with significant economic impact. As diagnostic tools have increased in sensitivity, understanding of the etiology of CAP has begun to change. Mycoplasma pneumoniae is one of the major pathogens causing CAP. Macrolides and related antibiotics are first-line treatments for M. pneumoniae. Macrolide resistance has been spreading for 15 years and now occurs in worldwide. We undertook the first study on macrolide resistance of M. pneumoniae in Yantai. This may be helpful to determine the appropriate therapy for CAP in this population.

Objective

To investigate the rate and mechanism of macrolide resistance in Yantai.

Methods

Pharyngeal swab samp

SUBMITTER: Yu HX 

PROVIDER: S-EPMC6084921 | biostudies-literature | 2018 Jun

REPOSITORIES: biostudies-literature